QDEL
QuidelOrtho CorporationNASDAQHealthcare$17.25+4.04%ClosedMarket Cap: $1.17B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.56
P/S
0.40
EV/EBITDA
-7.59
DCF Value
$-44.30
FCF Yield
2.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.7%
Operating Margin
-33.7%
Net Margin
-41.5%
ROE
-46.4%
ROA
-19.6%
ROIC
-18.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $723.6M | 44.3% | $-66.3M | $-130.7M | $-1.95 | — |
| FY 2025 | $2.73B | 46.7% | $-919.2M | $-1.13B | $-16.69 | — |
| Q3 2025 | $699.9M | 47.9% | $-704.8M | $-733.0M | $-10.78 | — |
| Q2 2025 | $613.9M | 44.8% | $-180.7M | $-255.4M | $-3.77 | — |
| Q1 2025 | $692.8M | 49.6% | $32.6M | $-12.7M | $-0.19 | — |
| Q4 2024 | $707.8M | 46.1% | $-100.4M | $-178.4M | $-2.28 | — |
| FY 2024 | $2.78B | 46.2% | $-1.96B | $-2.05B | $-30.54 | — |
| Q3 2024 | $727.1M | 48.5% | $15.0M | $-19.9M | $-0.30 | — |
| Q2 2024 | $637.0M | 43.3% | $-117.5M | $-147.7M | $-2.20 | — |
| Q1 2024 | $711.0M | 46.7% | $-1.76B | $-1.71B | $-25.50 | — |
| Q4 2023 | $742.6M | 51.3% | $40.1M | $7.0M | $0.10 | — |
| FY 2023 | $3.00B | 49.9% | $139.1M | $-10.1M | $-0.15 | — |